cas 1159977-56-6|| where to buy 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindoline-2,3-dione

Produktname:5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindoline-2,3-dione

IUPAC Name:5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-2,3-dihydro-1H-indole-2,3-dione

: CAS：1159977-56-6; Molekulare Formel：C21H19ClN4O2S; Reinheit：95%

Packungseinheit	Verfügbarer Vorrat	Preis($)
CM148361-250mg	in stock	ȯȐǫ
CM148361-1g	1-2 Weeks	ǫŪǫƛ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:1159977-56-6; Molekulare Formel:C21H19ClN4O2S; Schmelzpunkt:-; SMILES-Code:O=C1NC2=C(C=C(CCN3CCN(C4=NSC5=CC=CC=C45)CC3)C(Cl)=C2)C1=O; Dichte:

: Katalognummer:CM148361; Molekulargewicht:426.92; Siedepunkt:; Mdl-Nr.:; Lagerung:Store at 2-8°C.

: Piperazines; Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.

: Benzoisothiazoles; Benzoisothiazole is a benzo derivative of isothiazole, which is a kind of bicyclic aromatic organic compound, which is formed by fusion of a six-membered benzene ring and a five-membered heterocyclic ring composed of two adjacent heteroatoms, N and S. Benzoisothiazoles are important pharmaceutical intermediates. Some benzoisothiazole derivatives exhibit potent cytotoxic and antitumor activities.

: Indolinediones; 2,3-Indolinedione derivatives have been identified as a novel class of promising agents for cancer treatment.